Xylocaine is one of 11 small molecule programs targeting Plantar Fasciitis. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
10 competitors in Plantar Fasciitis
Medrol
Marcaine
Xylocaine
Xylocaine
Botox
Xylocaine
Platelet Rich Plasma
Platelet-Rich Fibrin (PRF)
Cortisone Acetate
Bone Marrow Aspirate
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details